Koyfin Home > Directory > Health Care > Intellia Thera CS > Gross Margin

Intellia Thera CS Gross Margin Chart (NTLA)

Intellia Thera CS annual/quarterly Gross Margin from 2015 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Intellia Thera CS Gross Margin for the quarter ending June 06, 2020 was $-132m a -20.35% increase of 27m year over year
  • Intellia Thera CS Gross Margin for the last 12 months ending June 06, 2020 was $-160m a 11.48% decrease of -18m year over year
  • Intellia Thera CS Annual Gross Margin for 2019 was $-152m a -27.25% increase of 41m from 2018
  • Intellia Thera CS Annual Gross Margin for 2018 was $-193m a 17.53% decrease of -34m from 2017
  • Intellia Thera CS Annual Gross Margin for 2017 was $-159m a 41.38% decrease of -66m from 2016
Other Margins & Efficiency Metrics:
  • Intellia Thera CS EBITDA Margin for the quarter ending December 12, 2018 was $-249m a 17.09% decrease of -42m year over year
  • Intellia Thera CS Return on Capital % for the quarter ending September 09, 2018 was -22.21 a -16.80% increase of 3.73 year over year
  • Intellia Thera CS Return on Equity % for the quarter ending September 09, 2018 was -33.47 a -20.21% increase of 6.77 year over year
View Chart On Koyfin

Quarterly NTLA Gross Margin Data

06/2020$-132m
03/2020$-168m
12/2019$-190m
09/2019$-159m
06/2019$-129m
03/2019$-127m
12/2018$-153m
09/2018$-214m
06/2018$-206m
03/2018$-201m

Annual NTLA Gross Margin Data

2019$-152m
2018$-193m
2017$-159m
2016$-93m
2015$-85m